Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine.
Identifieur interne : 000780 ( Main/Exploration ); précédent : 000779; suivant : 000781Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine.
Auteurs : James B. Fink [États-Unis] ; Stephan Ehrmann [France] ; Jie Li [États-Unis] ; Patricia Dailey [Irlande (pays)] ; Paul Mckiernan [Irlande (pays)] ; Chantal Darquenne [États-Unis] ; Andrew R. Martin [Canada] ; Barbara Rothen-Rutishauser [Suisse] ; Philip J. Kuehl [États-Unis] ; Sabine H Ussermann [Allemagne] ; Ronan Macloughlin [Irlande (pays)] ; Gerald C. Smaldone [États-Unis] ; Bernhard Muellinger [Allemagne] ; Timothy E. Corcoran [États-Unis] ; Rajiv Dhand [États-Unis]Source :
- Journal of aerosol medicine and pulmonary drug delivery [ 1941-2703 ] ; 2020.
Abstract
National and international guidelines recommend droplet/airborne transmission and contact precautions for those caring for coronavirus disease 2019 (COVID-19) patients in ambulatory and acute care settings. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, an acute respiratory infectious agent, is primarily transmitted between people through respiratory droplets and contact routes. A recognized key to transmission of COVID-19, and droplet infections generally, is the dispersion of bioaerosols from the patient. Increased risk of transmission has been associated with aerosol generating procedures that include endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, noninvasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. The knowledge that COVID-19 subjects can be asymptomatic and still shed virus, producing infectious droplets during breathing, suggests that health care workers (HCWs) should assume every patient is potentially infectious during this pandemic. Taking actions to reduce risk of transmission to HCWs is, therefore, a vital consideration for safe delivery of all medical aerosols. Guidelines for use of personal protective equipment (glove, gowns, masks, shield, and/or powered air purifying respiratory) during high-risk procedures are essential and should be considered for use with lower risk procedures such as administration of uncontaminated medical aerosols. Bioaerosols generated by infected patients are a major source of transmission for SARS CoV-2, and other infectious agents. In contrast, therapeutic aerosols do not add to the risk of disease transmission unless contaminated by patients or HCWs.
DOI: 10.1089/jamp.2020.1615
PubMed: 32783675
Affiliations:
- Allemagne, Canada, France, Irlande (pays), Suisse, États-Unis
- Alberta, Californie, Canton de Fribourg, Centre-Val de Loire, Illinois, Nouveau-Mexique, Pennsylvanie, Région Centre, Tennessee, État de New York
- Edmonton, Fribourg, Pittsburgh, Tours
- Université de Fribourg, Université de Pittsburgh, Université de Tours
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine.</title><author><name sortKey="Fink, James B" sort="Fink, James B" uniqKey="Fink J" first="James B" last="Fink">James B. Fink</name><affiliation wicri:level="2"><nlm:affiliation>Aerogen Pharma Corp., San Mateo, California, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Aerogen Pharma Corp., San Mateo, California</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation><affiliation wicri:level="2"><nlm:affiliation>Division of Respiratory Care, Department of Cardiopulmonary Sciences, Rush University Medical Center, Chicago, Illinois, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Respiratory Care, Department of Cardiopulmonary Sciences, Rush University Medical Center, Chicago, Illinois</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation></author><author><name sortKey="Ehrmann, Stephan" sort="Ehrmann, Stephan" uniqKey="Ehrmann S" first="Stephan" last="Ehrmann">Stephan Ehrmann</name><affiliation wicri:level="3"><nlm:affiliation>CHRU Tours, Médecine Intensive Réanimation, CIC INSERM 1415, CRICS-TriggerSep Research Network, Tours, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>CHRU Tours, Médecine Intensive Réanimation, CIC INSERM 1415, CRICS-TriggerSep Research Network, Tours</wicri:regionArea><placeName><region type="region">Centre-Val de Loire</region><region type="old region">Région Centre</region><settlement type="city">Tours</settlement></placeName></affiliation><affiliation wicri:level="4"><nlm:affiliation>INSERM, Centre d'étude des Pathologies Respiratoires, U1100, Université de Tours, Tours, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM, Centre d'étude des Pathologies Respiratoires, U1100, Université de Tours, Tours</wicri:regionArea><placeName><region type="region">Centre-Val de Loire</region><region type="old region">Région Centre</region><settlement type="city">Tours</settlement></placeName><orgName type="university">Université de Tours</orgName></affiliation></author><author><name sortKey="Li, Jie" sort="Li, Jie" uniqKey="Li J" first="Jie" last="Li">Jie Li</name><affiliation wicri:level="2"><nlm:affiliation>Division of Respiratory Care, Department of Cardiopulmonary Sciences, Rush University Medical Center, Chicago, Illinois, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Respiratory Care, Department of Cardiopulmonary Sciences, Rush University Medical Center, Chicago, Illinois</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation></author><author><name sortKey="Dailey, Patricia" sort="Dailey, Patricia" uniqKey="Dailey P" first="Patricia" last="Dailey">Patricia Dailey</name><affiliation wicri:level="1"><nlm:affiliation>Aerogen Limited, Galway, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>Aerogen Limited, Galway</wicri:regionArea><wicri:noRegion>Galway</wicri:noRegion></affiliation></author><author><name sortKey="Mckiernan, Paul" sort="Mckiernan, Paul" uniqKey="Mckiernan P" first="Paul" last="Mckiernan">Paul Mckiernan</name><affiliation wicri:level="1"><nlm:affiliation>Aerogen Limited, Galway, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>Aerogen Limited, Galway</wicri:regionArea><wicri:noRegion>Galway</wicri:noRegion></affiliation></author><author><name sortKey="Darquenne, Chantal" sort="Darquenne, Chantal" uniqKey="Darquenne C" first="Chantal" last="Darquenne">Chantal Darquenne</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, University of California, San Diego, California, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, University of California, San Diego, California</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Martin, Andrew R" sort="Martin, Andrew R" uniqKey="Martin A" first="Andrew R" last="Martin">Andrew R. Martin</name><affiliation wicri:level="3"><nlm:affiliation>Mechanical Engineering, University of Alberta, Edmonton, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Mechanical Engineering, University of Alberta, Edmonton</wicri:regionArea><placeName><settlement type="city">Edmonton</settlement><region type="state">Alberta</region></placeName></affiliation></author><author><name sortKey="Rothen Rutishauser, Barbara" sort="Rothen Rutishauser, Barbara" uniqKey="Rothen Rutishauser B" first="Barbara" last="Rothen-Rutishauser">Barbara Rothen-Rutishauser</name><affiliation wicri:level="4"><nlm:affiliation>Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Adolphe Merkle Institute, University of Fribourg, Fribourg</wicri:regionArea><orgName type="university">Université de Fribourg</orgName><placeName><settlement type="city">Fribourg</settlement><region nuts="3" type="region">Canton de Fribourg</region></placeName></affiliation></author><author><name sortKey="Kuehl, Philip J" sort="Kuehl, Philip J" uniqKey="Kuehl P" first="Philip J" last="Kuehl">Philip J. Kuehl</name><affiliation wicri:level="2"><nlm:affiliation>Lovelace Biomedical, Albuquerque, New Mexico, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Lovelace Biomedical, Albuquerque, New Mexico</wicri:regionArea><placeName><region type="state">Nouveau-Mexique</region></placeName></affiliation></author><author><name sortKey="H Ussermann, Sabine" sort="H Ussermann, Sabine" uniqKey="H Ussermann S" first="Sabine" last="H Ussermann">Sabine H Ussermann</name><affiliation wicri:level="1"><nlm:affiliation>VisionHealth GmbH, Garching Forschungszentrum, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>VisionHealth GmbH, Garching Forschungszentrum</wicri:regionArea><wicri:noRegion>Garching Forschungszentrum</wicri:noRegion><wicri:noRegion>Garching Forschungszentrum</wicri:noRegion><wicri:noRegion>Garching Forschungszentrum</wicri:noRegion></affiliation></author><author><name sortKey="Macloughlin, Ronan" sort="Macloughlin, Ronan" uniqKey="Macloughlin R" first="Ronan" last="Macloughlin">Ronan Macloughlin</name><affiliation wicri:level="1"><nlm:affiliation>Aerogen Limited, Galway, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>Aerogen Limited, Galway</wicri:regionArea><wicri:noRegion>Galway</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons, Dublin, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons, Dublin</wicri:regionArea><wicri:noRegion>Dublin</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin</wicri:regionArea><wicri:noRegion>Dublin</wicri:noRegion></affiliation></author><author><name sortKey="Smaldone, Gerald C" sort="Smaldone, Gerald C" uniqKey="Smaldone G" first="Gerald C" last="Smaldone">Gerald C. Smaldone</name><affiliation wicri:level="2"><nlm:affiliation>Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, State University of New York at Stony Brook, Stony Brook, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, State University of New York at Stony Brook, Stony Brook, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Muellinger, Bernhard" sort="Muellinger, Bernhard" uniqKey="Muellinger B" first="Bernhard" last="Muellinger">Bernhard Muellinger</name><affiliation wicri:level="1"><nlm:affiliation>Vectura GmbH, Gauting, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Vectura GmbH, Gauting</wicri:regionArea><wicri:noRegion>Gauting</wicri:noRegion><wicri:noRegion>Gauting</wicri:noRegion><wicri:noRegion>Gauting</wicri:noRegion></affiliation></author><author><name sortKey="Corcoran, Timothy E" sort="Corcoran, Timothy E" uniqKey="Corcoran T" first="Timothy E" last="Corcoran">Timothy E. Corcoran</name><affiliation wicri:level="4"><nlm:affiliation>Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania</wicri:regionArea><placeName><region type="state">Pennsylvanie</region><settlement type="city">Pittsburgh</settlement></placeName><orgName type="university">Université de Pittsburgh</orgName></affiliation></author><author><name sortKey="Dhand, Rajiv" sort="Dhand, Rajiv" uniqKey="Dhand R" first="Rajiv" last="Dhand">Rajiv Dhand</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Graduate School of Medicine, University of Tennessee Health Science Center, Knoxville, Tennessee, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Graduate School of Medicine, University of Tennessee Health Science Center, Knoxville, Tennessee</wicri:regionArea><placeName><region type="state">Tennessee</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32783675</idno><idno type="pmid">32783675</idno><idno type="doi">10.1089/jamp.2020.1615</idno><idno type="wicri:Area/Main/Corpus">000633</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000633</idno><idno type="wicri:Area/Main/Curation">000633</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000633</idno><idno type="wicri:Area/Main/Exploration">000633</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine.</title><author><name sortKey="Fink, James B" sort="Fink, James B" uniqKey="Fink J" first="James B" last="Fink">James B. Fink</name><affiliation wicri:level="2"><nlm:affiliation>Aerogen Pharma Corp., San Mateo, California, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Aerogen Pharma Corp., San Mateo, California</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation><affiliation wicri:level="2"><nlm:affiliation>Division of Respiratory Care, Department of Cardiopulmonary Sciences, Rush University Medical Center, Chicago, Illinois, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Respiratory Care, Department of Cardiopulmonary Sciences, Rush University Medical Center, Chicago, Illinois</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation></author><author><name sortKey="Ehrmann, Stephan" sort="Ehrmann, Stephan" uniqKey="Ehrmann S" first="Stephan" last="Ehrmann">Stephan Ehrmann</name><affiliation wicri:level="3"><nlm:affiliation>CHRU Tours, Médecine Intensive Réanimation, CIC INSERM 1415, CRICS-TriggerSep Research Network, Tours, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>CHRU Tours, Médecine Intensive Réanimation, CIC INSERM 1415, CRICS-TriggerSep Research Network, Tours</wicri:regionArea><placeName><region type="region">Centre-Val de Loire</region><region type="old region">Région Centre</region><settlement type="city">Tours</settlement></placeName></affiliation><affiliation wicri:level="4"><nlm:affiliation>INSERM, Centre d'étude des Pathologies Respiratoires, U1100, Université de Tours, Tours, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM, Centre d'étude des Pathologies Respiratoires, U1100, Université de Tours, Tours</wicri:regionArea><placeName><region type="region">Centre-Val de Loire</region><region type="old region">Région Centre</region><settlement type="city">Tours</settlement></placeName><orgName type="university">Université de Tours</orgName></affiliation></author><author><name sortKey="Li, Jie" sort="Li, Jie" uniqKey="Li J" first="Jie" last="Li">Jie Li</name><affiliation wicri:level="2"><nlm:affiliation>Division of Respiratory Care, Department of Cardiopulmonary Sciences, Rush University Medical Center, Chicago, Illinois, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Respiratory Care, Department of Cardiopulmonary Sciences, Rush University Medical Center, Chicago, Illinois</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation></author><author><name sortKey="Dailey, Patricia" sort="Dailey, Patricia" uniqKey="Dailey P" first="Patricia" last="Dailey">Patricia Dailey</name><affiliation wicri:level="1"><nlm:affiliation>Aerogen Limited, Galway, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>Aerogen Limited, Galway</wicri:regionArea><wicri:noRegion>Galway</wicri:noRegion></affiliation></author><author><name sortKey="Mckiernan, Paul" sort="Mckiernan, Paul" uniqKey="Mckiernan P" first="Paul" last="Mckiernan">Paul Mckiernan</name><affiliation wicri:level="1"><nlm:affiliation>Aerogen Limited, Galway, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>Aerogen Limited, Galway</wicri:regionArea><wicri:noRegion>Galway</wicri:noRegion></affiliation></author><author><name sortKey="Darquenne, Chantal" sort="Darquenne, Chantal" uniqKey="Darquenne C" first="Chantal" last="Darquenne">Chantal Darquenne</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, University of California, San Diego, California, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, University of California, San Diego, California</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Martin, Andrew R" sort="Martin, Andrew R" uniqKey="Martin A" first="Andrew R" last="Martin">Andrew R. Martin</name><affiliation wicri:level="3"><nlm:affiliation>Mechanical Engineering, University of Alberta, Edmonton, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Mechanical Engineering, University of Alberta, Edmonton</wicri:regionArea><placeName><settlement type="city">Edmonton</settlement><region type="state">Alberta</region></placeName></affiliation></author><author><name sortKey="Rothen Rutishauser, Barbara" sort="Rothen Rutishauser, Barbara" uniqKey="Rothen Rutishauser B" first="Barbara" last="Rothen-Rutishauser">Barbara Rothen-Rutishauser</name><affiliation wicri:level="4"><nlm:affiliation>Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Adolphe Merkle Institute, University of Fribourg, Fribourg</wicri:regionArea><orgName type="university">Université de Fribourg</orgName><placeName><settlement type="city">Fribourg</settlement><region nuts="3" type="region">Canton de Fribourg</region></placeName></affiliation></author><author><name sortKey="Kuehl, Philip J" sort="Kuehl, Philip J" uniqKey="Kuehl P" first="Philip J" last="Kuehl">Philip J. Kuehl</name><affiliation wicri:level="2"><nlm:affiliation>Lovelace Biomedical, Albuquerque, New Mexico, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Lovelace Biomedical, Albuquerque, New Mexico</wicri:regionArea><placeName><region type="state">Nouveau-Mexique</region></placeName></affiliation></author><author><name sortKey="H Ussermann, Sabine" sort="H Ussermann, Sabine" uniqKey="H Ussermann S" first="Sabine" last="H Ussermann">Sabine H Ussermann</name><affiliation wicri:level="1"><nlm:affiliation>VisionHealth GmbH, Garching Forschungszentrum, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>VisionHealth GmbH, Garching Forschungszentrum</wicri:regionArea><wicri:noRegion>Garching Forschungszentrum</wicri:noRegion><wicri:noRegion>Garching Forschungszentrum</wicri:noRegion><wicri:noRegion>Garching Forschungszentrum</wicri:noRegion></affiliation></author><author><name sortKey="Macloughlin, Ronan" sort="Macloughlin, Ronan" uniqKey="Macloughlin R" first="Ronan" last="Macloughlin">Ronan Macloughlin</name><affiliation wicri:level="1"><nlm:affiliation>Aerogen Limited, Galway, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>Aerogen Limited, Galway</wicri:regionArea><wicri:noRegion>Galway</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons, Dublin, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons, Dublin</wicri:regionArea><wicri:noRegion>Dublin</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:affiliation>School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, Ireland.</nlm:affiliation><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin</wicri:regionArea><wicri:noRegion>Dublin</wicri:noRegion></affiliation></author><author><name sortKey="Smaldone, Gerald C" sort="Smaldone, Gerald C" uniqKey="Smaldone G" first="Gerald C" last="Smaldone">Gerald C. Smaldone</name><affiliation wicri:level="2"><nlm:affiliation>Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, State University of New York at Stony Brook, Stony Brook, New York, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, State University of New York at Stony Brook, Stony Brook, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Muellinger, Bernhard" sort="Muellinger, Bernhard" uniqKey="Muellinger B" first="Bernhard" last="Muellinger">Bernhard Muellinger</name><affiliation wicri:level="1"><nlm:affiliation>Vectura GmbH, Gauting, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Vectura GmbH, Gauting</wicri:regionArea><wicri:noRegion>Gauting</wicri:noRegion><wicri:noRegion>Gauting</wicri:noRegion><wicri:noRegion>Gauting</wicri:noRegion></affiliation></author><author><name sortKey="Corcoran, Timothy E" sort="Corcoran, Timothy E" uniqKey="Corcoran T" first="Timothy E" last="Corcoran">Timothy E. Corcoran</name><affiliation wicri:level="4"><nlm:affiliation>Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania</wicri:regionArea><placeName><region type="state">Pennsylvanie</region><settlement type="city">Pittsburgh</settlement></placeName><orgName type="university">Université de Pittsburgh</orgName></affiliation></author><author><name sortKey="Dhand, Rajiv" sort="Dhand, Rajiv" uniqKey="Dhand R" first="Rajiv" last="Dhand">Rajiv Dhand</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Graduate School of Medicine, University of Tennessee Health Science Center, Knoxville, Tennessee, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Graduate School of Medicine, University of Tennessee Health Science Center, Knoxville, Tennessee</wicri:regionArea><placeName><region type="state">Tennessee</region></placeName></affiliation></author></analytic><series><title level="j">Journal of aerosol medicine and pulmonary drug delivery</title><idno type="eISSN">1941-2703</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">National and international guidelines recommend droplet/airborne transmission and contact precautions for those caring for coronavirus disease 2019 (COVID-19) patients in ambulatory and acute care settings. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, an acute respiratory infectious agent, is primarily transmitted between people through respiratory droplets and contact routes. A recognized key to transmission of COVID-19, and droplet infections generally, is the dispersion of bioaerosols from the patient. Increased risk of transmission has been associated with aerosol generating procedures that include endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, noninvasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. The knowledge that COVID-19 subjects can be asymptomatic and still shed virus, producing infectious droplets during breathing, suggests that health care workers (HCWs) should assume every patient is potentially infectious during this pandemic. Taking actions to reduce risk of transmission to HCWs is, therefore, a vital consideration for safe delivery of all medical aerosols. Guidelines for use of personal protective equipment (glove, gowns, masks, shield, and/or powered air purifying respiratory) during high-risk procedures are essential and should be considered for use with lower risk procedures such as administration of uncontaminated medical aerosols. Bioaerosols generated by infected patients are a major source of transmission for SARS CoV-2, and other infectious agents. In contrast, therapeutic aerosols do not add to the risk of disease transmission unless contaminated by patients or HCWs.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32783675</PMID><DateRevised><Year>2020</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1941-2703</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Aug</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of aerosol medicine and pulmonary drug delivery</Title><ISOAbbreviation>J Aerosol Med Pulm Drug Deliv</ISOAbbreviation></Journal><ArticleTitle>Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1089/jamp.2020.1615</ELocationID><Abstract><AbstractText>National and international guidelines recommend droplet/airborne transmission and contact precautions for those caring for coronavirus disease 2019 (COVID-19) patients in ambulatory and acute care settings. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, an acute respiratory infectious agent, is primarily transmitted between people through respiratory droplets and contact routes. A recognized key to transmission of COVID-19, and droplet infections generally, is the dispersion of bioaerosols from the patient. Increased risk of transmission has been associated with aerosol generating procedures that include endotracheal intubation, bronchoscopy, open suctioning, administration of nebulized treatment, manual ventilation before intubation, turning the patient to the prone position, disconnecting the patient from the ventilator, noninvasive positive-pressure ventilation, tracheostomy, and cardiopulmonary resuscitation. The knowledge that COVID-19 subjects can be asymptomatic and still shed virus, producing infectious droplets during breathing, suggests that health care workers (HCWs) should assume every patient is potentially infectious during this pandemic. Taking actions to reduce risk of transmission to HCWs is, therefore, a vital consideration for safe delivery of all medical aerosols. Guidelines for use of personal protective equipment (glove, gowns, masks, shield, and/or powered air purifying respiratory) during high-risk procedures are essential and should be considered for use with lower risk procedures such as administration of uncontaminated medical aerosols. Bioaerosols generated by infected patients are a major source of transmission for SARS CoV-2, and other infectious agents. In contrast, therapeutic aerosols do not add to the risk of disease transmission unless contaminated by patients or HCWs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fink</LastName><ForeName>James B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Aerogen Pharma Corp., San Mateo, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respiratory Care, Department of Cardiopulmonary Sciences, Rush University Medical Center, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ehrmann</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CHRU Tours, Médecine Intensive Réanimation, CIC INSERM 1415, CRICS-TriggerSep Research Network, Tours, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM, Centre d'étude des Pathologies Respiratoires, U1100, Université de Tours, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Respiratory Care, Department of Cardiopulmonary Sciences, Rush University Medical Center, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dailey</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Aerogen Limited, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKiernan</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Aerogen Limited, Galway, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darquenne</LastName><ForeName>Chantal</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Diego, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Andrew R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Mechanical Engineering, University of Alberta, Edmonton, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothen-Rutishauser</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuehl</LastName><ForeName>Philip J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Lovelace Biomedical, Albuquerque, New Mexico, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Häussermann</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>VisionHealth GmbH, Garching Forschungszentrum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacLoughlin</LastName><ForeName>Ronan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Aerogen Limited, Galway, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smaldone</LastName><ForeName>Gerald C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, State University of New York at Stony Brook, Stony Brook, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muellinger</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Vectura GmbH, Gauting, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corcoran</LastName><ForeName>Timothy E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhand</LastName><ForeName>Rajiv</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, Graduate School of Medicine, University of Tennessee Health Science Center, Knoxville, Tennessee, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Aerosol Med Pulm Drug Deliv</MedlineTA><NlmUniqueID>101475057</NlmUniqueID><ISSNLinking>1941-2711</ISSNLinking></MedlineJournalInfo><CitationSubset>T</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">aerosol generating procedures</Keyword><Keyword MajorTopicYN="N">bioaerosol dispersion</Keyword><Keyword MajorTopicYN="N">filters</Keyword><Keyword MajorTopicYN="N">medical aerosol</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32783675</ArticleId><ArticleId IdType="doi">10.1089/jamp.2020.1615</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li><li>Canada</li><li>France</li><li>Irlande (pays)</li><li>Suisse</li><li>États-Unis</li></country><region><li>Alberta</li><li>Californie</li><li>Canton de Fribourg</li><li>Centre-Val de Loire</li><li>Illinois</li><li>Nouveau-Mexique</li><li>Pennsylvanie</li><li>Région Centre</li><li>Tennessee</li><li>État de New York</li></region><settlement><li>Edmonton</li><li>Fribourg</li><li>Pittsburgh</li><li>Tours</li></settlement><orgName><li>Université de Fribourg</li><li>Université de Pittsburgh</li><li>Université de Tours</li></orgName></list><tree><country name="États-Unis"><region name="Californie"><name sortKey="Fink, James B" sort="Fink, James B" uniqKey="Fink J" first="James B" last="Fink">James B. Fink</name></region><name sortKey="Corcoran, Timothy E" sort="Corcoran, Timothy E" uniqKey="Corcoran T" first="Timothy E" last="Corcoran">Timothy E. Corcoran</name><name sortKey="Darquenne, Chantal" sort="Darquenne, Chantal" uniqKey="Darquenne C" first="Chantal" last="Darquenne">Chantal Darquenne</name><name sortKey="Dhand, Rajiv" sort="Dhand, Rajiv" uniqKey="Dhand R" first="Rajiv" last="Dhand">Rajiv Dhand</name><name sortKey="Fink, James B" sort="Fink, James B" uniqKey="Fink J" first="James B" last="Fink">James B. Fink</name><name sortKey="Kuehl, Philip J" sort="Kuehl, Philip J" uniqKey="Kuehl P" first="Philip J" last="Kuehl">Philip J. Kuehl</name><name sortKey="Li, Jie" sort="Li, Jie" uniqKey="Li J" first="Jie" last="Li">Jie Li</name><name sortKey="Smaldone, Gerald C" sort="Smaldone, Gerald C" uniqKey="Smaldone G" first="Gerald C" last="Smaldone">Gerald C. Smaldone</name></country><country name="France"><region name="Centre-Val de Loire"><name sortKey="Ehrmann, Stephan" sort="Ehrmann, Stephan" uniqKey="Ehrmann S" first="Stephan" last="Ehrmann">Stephan Ehrmann</name></region><name sortKey="Ehrmann, Stephan" sort="Ehrmann, Stephan" uniqKey="Ehrmann S" first="Stephan" last="Ehrmann">Stephan Ehrmann</name></country><country name="Irlande (pays)"><noRegion><name sortKey="Dailey, Patricia" sort="Dailey, Patricia" uniqKey="Dailey P" first="Patricia" last="Dailey">Patricia Dailey</name></noRegion><name sortKey="Macloughlin, Ronan" sort="Macloughlin, Ronan" uniqKey="Macloughlin R" first="Ronan" last="Macloughlin">Ronan Macloughlin</name><name sortKey="Macloughlin, Ronan" sort="Macloughlin, Ronan" uniqKey="Macloughlin R" first="Ronan" last="Macloughlin">Ronan Macloughlin</name><name sortKey="Macloughlin, Ronan" sort="Macloughlin, Ronan" uniqKey="Macloughlin R" first="Ronan" last="Macloughlin">Ronan Macloughlin</name><name sortKey="Mckiernan, Paul" sort="Mckiernan, Paul" uniqKey="Mckiernan P" first="Paul" last="Mckiernan">Paul Mckiernan</name></country><country name="Canada"><region name="Alberta"><name sortKey="Martin, Andrew R" sort="Martin, Andrew R" uniqKey="Martin A" first="Andrew R" last="Martin">Andrew R. Martin</name></region></country><country name="Suisse"><region name="Canton de Fribourg"><name sortKey="Rothen Rutishauser, Barbara" sort="Rothen Rutishauser, Barbara" uniqKey="Rothen Rutishauser B" first="Barbara" last="Rothen-Rutishauser">Barbara Rothen-Rutishauser</name></region></country><country name="Allemagne"><noRegion><name sortKey="H Ussermann, Sabine" sort="H Ussermann, Sabine" uniqKey="H Ussermann S" first="Sabine" last="H Ussermann">Sabine H Ussermann</name></noRegion><name sortKey="Muellinger, Bernhard" sort="Muellinger, Bernhard" uniqKey="Muellinger B" first="Bernhard" last="Muellinger">Bernhard Muellinger</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000780 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000780 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32783675
|texte= Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32783675" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |